Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.
Letrozol
CAS NO:112809-51-5
Molecular Formula:C17H11N5
Content:98%
Properties:White or white crystall powder.
Packing:1kg/aluminum foil bag
USES: pharmaceutical intermediates, postmenopausal metastatic breast cancer,
more for anti-estrogen therapy after the failure second-line therapy.